Location History:
- Rosemont, PA (US) (2013 - 2014)
- Bryn Mawr, PA (US) (2008 - 2018)
Company Filing History:
6 out of 6 
3 out of 3 
2 out of 2 Years Active: 2008-2018
Title: Innovations by Claresa S Levetan
Introduction
Claressa S Levetan is a prominent inventor based in Rosemont, PA, known for her significant contributions to the field of diabetes treatment. With a total of 18 patents to her name, she has dedicated her career to developing novel therapies that aim to improve the lives of patients with diabetes. Her innovative approaches have garnered attention in the medical community.
Latest Patents
One of her latest patents focuses on achieving insulin independence among patients with diabetes through the use of an optimized hamster REG3 gamma peptide. This invention presents new therapies, pharmaceutical compositions, and methods that have not been previously considered in the 30 years since the discovery of the REG3 gamma peptide. The methods outlined in her patent aim to render patients with recent onset and existing type 1 diabetes insulin independent by utilizing this optimized peptide along with an immune tolerance agent. Additionally, it can be used alone for type 2 diabetes patients. The optimized REG3 gamma peptides have shown potential in increasing beta cell generation by transforming ductal pancreatic cells into new islets.
Career Highlights
Throughout her career, Claressa has worked with various organizations, including Curedm Group Holdings, LLC. Her work has been instrumental in advancing diabetes treatment options and has positioned her as a leader in her field.
Collaborations
Claressa has collaborated with notable individuals such as Loraine V Upham and Victor M Garsky, contributing to the development of her innovative therapies.
Conclusion
Claressa S Levetan's work in the field of diabetes treatment exemplifies the impact of innovation on healthcare. Her dedication to developing new therapies continues to inspire advancements in medical science.